Methylphenidate effective on range of symptoms in PTSD, brain injury

A placebo‐controlled trial of the stimulant methylphenidate or the cholinesterase inhibitor galantamine for cognitive and emotional symptoms in patients with post‐traumatic stress disorder (PTSD) and/or traumatic brain injury (TBI) found a broad range of positive outcomes associated with methylphenidate. This included the surprising finding of improvement in PTSD symptoms. Effects were not as pronounced for galantamine, although patients receiving that drug did show improvement on a measure of episodic memory. Results were published online Oct. 28, 2015, in Neuropsychopharmacology.
Source: The Brown University Psychopharmacology Update - Category: Psychiatry Tags: Cognitive Treatments Source Type: research